German docs can take pharma gifts, court says; Sanofi pulls vaccine batches Down Under;

 @FiercePharma: Andrew Witty's letter to EU urges reference pricing, parallel trade changes to keep meds flowing to Greece, et al. Report | Follow @FiercePharma

> German physicians can accept gifts and junkets from drugmakers without fear of corruption allegations, a top court ruled, saying they're not state representatives but freelance workers. Report

> Sanofi ($SNY) yanked four batches of its Bacillus Calmette-Guerin tuberculosis vaccine in Australia because of questions about its sterility. Article

> Boehringer Ingelheim is scouting for over-the-counter products to buy in India, domestic media reports. Report

> Wisconsin's Supreme Court upheld a $9 million damages ruling against Pharmacia, now a unit of Pfizer ($PFE), for inflating drug prices reported to Medicaid. Report

> Amgen ($AMGN) has teamed up with actress Maura Tierney on a patient-awareness campaign about chemotherapy. Release

> European regulators said currently approved doses of the antibiotic Doribax may be strong enough to treat all patients with hospital-acquired pneumonia. Story

> Indian drugmakers have failed to respond to government charges that they overcharged for drugs. Report

Biotech News

 @FierceBiotech: : Immunotherapies make a comeback at Big | Follow @FierceBiotech

 @JohnCFierce: Merck Serono and Compugen are starting up a new biomarkers co. for drug-induced toxicity. Release | Follow @JohnCFierce

 @RyanMFierce: FierceBiotech IT lands in Philly for DIA summit, let me know how we're doing. More | Follow @RyanMFierce

> FDA rejects blockbuster Eliquis bid, asks Pfizer, BMS for trial clarification. News

> Price curmudgeons at NICE prep early-stage advice for VCs. Story

> Lexicon boasts of positive results in PhIIb diabetes study. Article

> Ventrus shares clobbered after failed PhIII forces it to regroup. Report

Medical Device News

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

 @MarkHFierce: Yet another reason why device and Dx companies are turning to China. Item | Follow @MarkHFierce

 @DamianFierce: Teleflex dropped $30M on an MIT spin-out for its safety-boosting device coating. Story | Follow @DamianFierce

> DSM closes $360M deal for Kensey Nash. More

> Arstasis draws $38M in new financing. Story

> St. Jude blames Durata lead failure on 'external abrasion.' Article

Biotech IT News

> Why Microsoft's Yammer buyout matters in pharma. Article

> Merck Serono, Compugen form startup to catch drug toxicity early. More

> Oracle rolls out cloud apps for clinical trial recruitment. Story

> Bay Area startup delivers clinical trials analytics from the cloud. News

And Finally... Living with a house dog may protect kids from a viral infection linked with asthma. Report